{{Rsnum
|rsid=4142110
|Gene=DGKH
|Chromosome=13
|position=42180386
|Orientation=plus
|GMAF=0.4008
|Gene_s=DGKH
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.2 | 45.1 | 40.7
| HCB | 22.6 | 54.0 | 23.4
| JPT | 35.4 | 48.7 | 15.9
| YRI | 0.7 | 17.0 | 82.3
| ASW | 8.8 | 33.3 | 57.9
| CHB | 22.6 | 54.0 | 23.4
| CHD | 26.6 | 50.5 | 22.9
| GIH | 15.8 | 51.5 | 32.7
| LWK | 0.9 | 27.3 | 71.8
| MEX | 29.3 | 43.1 | 27.6
| MKK | 0.6 | 29.5 | 69.9
| TSI | 10.8 | 48.0 | 41.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22396660
|Trait=None
|Title=A genome-wide association study of nephrolithiasis in the Japanese population identifies novel susceptible Loci at 5q35.3, 7p14.3, and 13q14.1.
|RiskAllele=
|Pval=5E-9
|OR=1.1400
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=25081328
|Title=Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}